{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:04:34Z","timestamp":1772784274339,"version":"3.50.1"},"reference-count":51,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Lipid raft-associated proteins play a vital role in membrane-mediated processes. The lipid microdomain-associated protein flotillin 2 (FLOT2), which has a scaffolding function, is involved in polarization, as well as in actin cytoskeletal organization of primitive and mature hematopoietic cells and has been associated with different malignancies. However, its involvement in myeloid leukemias is not well studied. Using murine transplantation models, we show here that the absence of FLOT2 from leukemia-initiating cells (LICs) altered the disease course of BCR-ABL1+ chronic myeloid leukemia (CML), but not of MLL\u2013AF9-driven acute myeloid leukemia (AML). While FLOT2 was required for expression of the adhesion molecule CD44 on both CML- and AML-LIC, a defect in the cytoskeleton, cell polarity, and impaired homing ability of LIC was only observed in FLOT2-deficient BCR-ABL1+ compared with MLL-AF9+ cells. Downstream of CD44, BCR-ABL1 kinase-independent discrepancies were observed regarding expression, localization, and activity of cell division control protein 42 homolog (CDC42) between wild-type (WT) and FLOT2-deficient human CML and AML cells. Inhibition of CDC42 by ML141 impaired the homing of CML LIC and, thereby, CML progression. This suggested that alteration of both CD44 and CDC42 may be causative of impaired CML progression in the absence of FLOT2. In summary, our data suggest a FLOT2-CD44-CDC42 axis, which differentially regulates CML vs AML progression, with deficiency of FLOT2 impairing the development of CML.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005992","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T18:37:52Z","timestamp":1647542272000},"page":"3611-3624","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":13,"title":["The differential role of the lipid raft-associated protein flotillin 2 for progression of myeloid leukemia"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0934-0859","authenticated-orcid":false,"given":"Rahul","family":"Kumar","sequence":"first","affiliation":[{"name":"1Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9863-6538","authenticated-orcid":false,"given":"Raquel S.","family":"Pereira","sequence":"additional","affiliation":[{"name":"1Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Niemann","sequence":"additional","affiliation":[{"name":"2Institute of Molecular Medicine, Ulm University, Ulm, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander I.","family":"Azimpour","sequence":"additional","affiliation":[{"name":"1Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costanza","family":"Zanetti","sequence":"additional","affiliation":[{"name":"1Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2161-914X","authenticated-orcid":false,"given":"Christina","family":"Karantanou","sequence":"additional","affiliation":[{"name":"1Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wahyu","family":"Minka","sequence":"additional","affiliation":[{"name":"1Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9296-9403","authenticated-orcid":false,"given":"Valentina R.","family":"Minciacchi","sequence":"additional","affiliation":[{"name":"1Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0447-8418","authenticated-orcid":false,"given":"Eric","family":"Kowarz","sequence":"additional","affiliation":[{"name":"3Institute of Pharmaceutical Biology, Goethe University, Frankfurt am Main, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0853-6750","authenticated-orcid":false,"given":"Melanie","family":"Meister","sequence":"additional","affiliation":[{"name":"1Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parimala S.","family":"Godavarthy","sequence":"additional","affiliation":[{"name":"4Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital T\u00fcbingen, T\u00fcbingen, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1556-068X","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Maguer-Satta","sequence":"additional","affiliation":[{"name":"5CRCL, INSERM U1052-CNRS UMR5286, Centre L\u00e9on B\u00e9rard, Lyon, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7320-4256","authenticated-orcid":false,"given":"Sylvain","family":"Lefort","sequence":"additional","affiliation":[{"name":"5CRCL, INSERM U1052-CNRS UMR5286, Centre L\u00e9on B\u00e9rard, Lyon, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8434-6492","authenticated-orcid":false,"given":"Eliza","family":"Wiercinska","sequence":"additional","affiliation":[{"name":"6German Red Cross Blood Service Baden-W\u00fcrttemberg-Hessen, Institute Frankfurt, Frankfurt, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0088-2675","authenticated-orcid":false,"given":"Halvard","family":"Bonig","sequence":"additional","affiliation":[{"name":"6German Red Cross Blood Service Baden-W\u00fcrttemberg-Hessen, Institute Frankfurt, Frankfurt, Germany;"},{"name":"7Goethe University, Institute for Transfusion Medicine and Immunohematology, Frankfurt, Germany;"},{"name":"8Division of Hematology, Department of Medicine, University of Washington, Seattle, WA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4870-3445","authenticated-orcid":false,"given":"Rolf","family":"Marschalek","sequence":"additional","affiliation":[{"name":"3Institute of Pharmaceutical Biology, Goethe University, Frankfurt am Main, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3603-1119","authenticated-orcid":false,"given":"Daniela S.","family":"Krause","sequence":"additional","affiliation":[{"name":"1Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany;"},{"name":"6German Red Cross Blood Service Baden-W\u00fcrttemberg-Hessen, Institute Frankfurt, Frankfurt, Germany;"},{"name":"9German Cancer Research Center (DKFZ), Heidelberg, Germany;"},{"name":"10German Cancer Consortium (DKTK), Germany;"},{"name":"11Frankfurt Cancer Institute, Frankfurt, Germany; and"},{"name":"12Institute for General Pharmacology and Toxicology, Institute for Biochemistry II, Goethe University, Frankfurt am Main, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"issue":"5","key":"2022062015230994400_B1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","article-title":"Bone marrow niches in haematological malignancies","volume":"20","author":"M\u00e9ndez-Ferrer","year":"2020","journal-title":"Nat Rev Cancer."},{"issue":"25","key":"2022062015230994400_B2","doi-asserted-by":"crossref","first-page":"13841","DOI":"10.1073\/pnas.250484797","article-title":"A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells","volume":"97","author":"Dimitroff","year":"2000","journal-title":"Proc Natl Acad Sci USA."},{"issue":"10","key":"2022062015230994400_B3","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/nm1489","article-title":"Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells","volume":"12","author":"Krause","year":"2006","journal-title":"Nat Med."},{"issue":"10","key":"2022062015230994400_B4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nm1483","article-title":"Targeting of CD44 eradicates human acute myeloid leukemic stem cells","volume":"12","author":"Jin","year":"2006","journal-title":"Nat Med."},{"issue":"1","key":"2022062015230994400_B5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3324\/haematol.2018.212365","article-title":"The vascular bone marrow niche influences outcome in chronic myeloid leukemia via the E-selectin - SCL\/TAL1 - CD44 axis","volume":"105","author":"Godavarthy","year":"2020","journal-title":"Haematologica."},{"issue":"9","key":"2022062015230994400_B6","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood-2013-11-538694","article-title":"Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche","volume":"123","author":"Krause","year":"2014","journal-title":"Blood."},{"issue":"4","key":"2022062015230994400_B7","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.4049\/jimmunol.1103026","article-title":"PSGL-1 regulates the migration and proliferation of CD8(+) T cells under homeostatic conditions","volume":"188","author":"Veerman","year":"2012","journal-title":"J Immunol."},{"issue":"4","key":"2022062015230994400_B8","doi-asserted-by":"crossref","first-page":"e5403","DOI":"10.1371\/journal.pone.0005403","article-title":"Flotillins interact with PSGL-1 in neutrophils and, upon stimulation, rapidly organize into membrane domains subsequently accumulating in the uropod","volume":"4","author":"Rossy","year":"2009","journal-title":"PLoS One."},{"issue":"1","key":"2022062015230994400_B9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1186\/1743-422X-8-479","article-title":"Research advances on flotillins","volume":"8","author":"Zhao","year":"2011","journal-title":"Virol J."},{"issue":"Pt 2","key":"2022062015230994400_B10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1042\/bj20031100","article-title":"Membrane and raft association of reggie-1\/flotillin-2: role of myristoylation, palmitoylation and oligomerization and induction of filopodia by overexpression","volume":"378","author":"Neumann-Giesen","year":"2004","journal-title":"Biochem J."},{"issue":"4","key":"2022062015230994400_B11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1083\/jcb.201005140","article-title":"Flotillin microdomains interact with the cortical cytoskeleton to control uropod formation and neutrophil recruitment","volume":"191","author":"Ludwig","year":"2010","journal-title":"J Cell Biol."},{"issue":"12","key":"2022062015230994400_B12","doi-asserted-by":"crossref","first-page":"e8290","DOI":"10.1371\/journal.pone.0008290","article-title":"Flotillins are involved in the polarization of primitive and mature hematopoietic cells","volume":"4","author":"Rajendran","year":"2009","journal-title":"PLoS One."},{"key":"2022062015230994400_B13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fimmu.2013.00084","article-title":"Ezrin\/radixin\/moesin proteins and flotillins cooperate to promote uropod formation in T cells","volume":"4","author":"Martinelli","year":"2013","journal-title":"Front Immunol."},{"issue":"1","key":"2022062015230994400_B14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2121-12-28","article-title":"Dynamic reorganization of flotillins in chemokine-stimulated human T-lymphocytes","volume":"12","author":"Affentranger","year":"2011","journal-title":"BMC Cell Biol."},{"issue":"3","key":"2022062015230994400_B15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/membranes4030356","article-title":"Endocytic trafficking of membrane-bound cargo: a flotillin point of view","volume":"4","author":"Meister","year":"2014","journal-title":"Membranes (Basel)."},{"issue":"13","key":"2022062015230994400_B16","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cub.2007.05.078","article-title":"Coassembly of flotillins induces formation of membrane microdomains, membrane curvature, and vesicle budding","volume":"17","author":"Frick","year":"2007","journal-title":"Curr Biol."},{"issue":"1","key":"2022062015230994400_B17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/cells3010129","article-title":"Flotillins in receptor tyrosine kinase signaling and cancer","volume":"3","author":"Banning","year":"2014","journal-title":"Cells."},{"issue":"Pt 3","key":"2022062015230994400_B18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1242\/jcs.03336","article-title":"Role of EGF-induced tyrosine phosphorylation of reggie-1\/flotillin-2 in cell spreading and signaling to the actin cytoskeleton","volume":"120","author":"Neumann-Giesen","year":"2007","journal-title":"J Cell Sci."},{"issue":"1","key":"2022062015230994400_B19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/1471-2407-13-575","article-title":"Phosphatidylinositol 3-kinase dependent upregulation of the epidermal growth factor receptor upon flotillin-1 depletion in breast cancer cells","volume":"13","author":"Kurrle","year":"2013","journal-title":"BMC Cancer."},{"issue":"5","key":"2022062015230994400_B20","first-page":"1068","article-title":"Flot2 promotes tumor growth and metastasis through modulating cell cycle and inducing epithelial-mesenchymal transition of hepatocellular carcinoma","volume":"7","author":"Wang","year":"2017","journal-title":"Am J Cancer Res."},{"issue":"7","key":"2022062015230994400_B21","doi-asserted-by":"crossref","first-page":"e0132190","DOI":"10.1371\/journal.pone.0132190","article-title":"Flot-2 expression correlates with EGFR levels and poor prognosis in surgically resected non-small cell lung cancer","volume":"10","author":"Wen","year":"2015","journal-title":"PLoS One."},{"issue":"10","key":"2022062015230994400_B22","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1074\/jbc.M111.287599","article-title":"Flotillin-1\/reggie-2 protein plays dual role in activation of receptor-tyrosine kinase\/mitogen-activated protein kinase signaling","volume":"287","author":"Amaddii","year":"2012","journal-title":"J Biol Chem."},{"issue":"11","key":"2022062015230994400_B23","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/nm.3364","article-title":"Differential regulation of myeloid leukemias by the bone marrow microenvironment","volume":"19","author":"Krause","year":"2013","journal-title":"Nat Med."},{"issue":"2","key":"2022062015230994400_B24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cellsig.2013.11.001","article-title":"Increased activity of mitogen activated protein kinase pathway in flotillin-2 knockout mouse model","volume":"26","author":"Banning","year":"2014","journal-title":"Cell Signal."},{"issue":"14","key":"2022062015230994400_B25","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2016-11-752923","article-title":"Granulocyte colony-stimulating factor mobilizes dormant hematopoietic stem cells without proliferation in mice","volume":"129","author":"Bernitz","year":"2017","journal-title":"Blood."},{"key":"2022062015230994400_B26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-4939-6780-3_13","article-title":"Isolation of lipid rafts through discontinuous sucrose gradient centrifugation and Fas\/CD95 death receptor localization in raft fractions","volume":"1557","author":"Gajate","year":"2017","journal-title":"Methods Mol Biol."},{"issue":"45","key":"2022062015230994400_B27","doi-asserted-by":"crossref","first-page":"16870","DOI":"10.1073\/pnas.0606509103","article-title":"Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice","volume":"103","author":"Hu","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"2022062015230994400_B28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-1-59745-418-6_5","article-title":"LDI-PCR: identification of known and unknown gene fusions of the human MLL gene","volume":"538","author":"Meyer","year":"2009","journal-title":"Methods Mol Biol."},{"issue":"7104","key":"2022062015230994400_B29","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature04980","article-title":"Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9","volume":"442","author":"Krivtsov","year":"2006","journal-title":"Nature."},{"issue":"8","key":"2022062015230994400_B30","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41375-020-0866-1","article-title":"Specific, targetable interactions with the microenvironment influence imatinib-resistant chronic myeloid leukemia","volume":"34","author":"Kumar","year":"2020","journal-title":"Leukemia."},{"issue":"4","key":"2022062015230994400_B31","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1083\/jcb.146.4.843","article-title":"Analysis of CD44-containing lipid rafts: recruitment of annexin II and stabilization by the actin cytoskeleton","volume":"146","author":"Oliferenko","year":"1999","journal-title":"J Cell Biol."},{"issue":"2","key":"2022062015230994400_B32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1521-6616(03)00097-4","article-title":"The flotillins are integral membrane proteins in lipid rafts that contain TCR-associated signaling components: implications for T-cell activation","volume":"108","author":"Slaughter","year":"2003","journal-title":"Clin Immunol."},{"issue":"7","key":"2022062015230994400_B33","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3390\/ijms21072283","article-title":"Flotillins: at the intersection of protein S-palmitoylation and lipid-mediated signaling","volume":"21","author":"Kwiatkowska","year":"2020","journal-title":"Int J Mol Sci."},{"issue":"D1","key":"2022062015230994400_B34","doi-asserted-by":"crossref","first-page":"D917","DOI":"10.1093\/nar\/gkv1101","article-title":"BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis","volume":"44","author":"Bagger","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"2022062015230994400_B35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrm1004","article-title":"CD44: from adhesion molecules to signalling regulators","volume":"4","author":"Ponta","year":"2003","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"3","key":"2022062015230994400_B36","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.4049\/jimmunol.173.3.1628","article-title":"Lipid raft-associated GTPase signaling controls morphology and CD8+ T cell stimulatory capacity of human dendritic cells","volume":"173","author":"Jaksits","year":"2004","journal-title":"J Immunol."},{"issue":"4","key":"2022062015230994400_B37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.semcancer.2008.03.007","article-title":"Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression","volume":"18","author":"Bourguignon","year":"2008","journal-title":"Semin Cancer Biol."},{"issue":"2","key":"2022062015230994400_B38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrc.2016.123","article-title":"Cancer cell motility: lessons from migration in confined spaces","volume":"17","author":"Paul","year":"2017","journal-title":"Nat Rev Cancer."},{"issue":"11","key":"2022062015230994400_B39","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1182\/blood-2016-12-758458","article-title":"The cell polarity determinant CDC42 controls division symmetry to block leukemia cell differentiation","volume":"130","author":"Mizukawa","year":"2017","journal-title":"Blood."},{"issue":"8","key":"2022062015230994400_B40","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/j.1432-1033.2004.04066.x","article-title":"Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells","volume":"271","author":"Jung","year":"2004","journal-title":"Eur J Biochem."},{"issue":"2","key":"2022062015230994400_B41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1042\/BJ20061686","article-title":"Reggie\/flotillin proteins are organized into stable tetramers in membrane microdomains","volume":"403","author":"Solis","year":"2007","journal-title":"Biochem J."},{"issue":"3","key":"2022062015230994400_B42","first-page":"2243","article-title":"Flotillin-2 predicts poor prognosis and promotes tumor invasion in intrahepatic cholangiocarcinoma","volume":"19","author":"Xu","year":"2020","journal-title":"Oncol Lett."},{"issue":"1","key":"2022062015230994400_B43","doi-asserted-by":"crossref","first-page":"11614","DOI":"10.1038\/srep11614","article-title":"Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-\u03baB and PI3K\/Akt3 signaling pathways","volume":"5","author":"Liu","year":"2015","journal-title":"Sci Rep."},{"issue":"3","key":"2022062015230994400_B44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1631\/jzus.B1700102","article-title":"Roles of flotillins in tumors","volume":"19","author":"Liu","year":"2018","journal-title":"J Zhejiang Univ Sci B."},{"issue":"2","key":"2022062015230994400_B45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10555-020-09873-y","article-title":"Flotillin membrane domains in cancer","volume":"39","author":"Gauthier-Rouvi\u00e8re","year":"2020","journal-title":"Cancer Metastasis Rev."},{"issue":"38","key":"2022062015230994400_B46","doi-asserted-by":"crossref","first-page":"39989","DOI":"10.1074\/jbc.M401080200","article-title":"Lipid rafts regulate lipopolysaccharide-induced activation of Cdc42 and inflammatory functions of the human neutrophil","volume":"279","author":"Fessler","year":"2004","journal-title":"J Biol Chem."},{"issue":"12","key":"2022062015230994400_B47","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1158\/0008-5472.CAN-18-0619","article-title":"Targeting Rac and Cdc42 GTPases in cancer","volume":"78","author":"Maldonado","year":"2018","journal-title":"Cancer Res."},{"issue":"4","key":"2022062015230994400_B48","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/molecules23040787","article-title":"Regulating Cdc42 and its signaling pathways in cancer: small molecules and microRNA as new treatment candidates","volume":"23","author":"Xiao","year":"2018","journal-title":"Molecules."},{"issue":"41","key":"2022062015230994400_B49","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1038\/sj.onc.1206626","article-title":"Differential interaction and activation of Rho family GTPases by p210bcr-abl and p190bcr-abl","volume":"22","author":"Harnois","year":"2003","journal-title":"Oncogene."},{"issue":"46","key":"2022062015230994400_B50","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1038\/onc.2009.260","article-title":"p210(Bcr-Abl) desensitizes Cdc42 GTPase signaling for SDF-1alpha-directed migration in chronic myeloid leukemia cells","volume":"28","author":"Chang","year":"2009","journal-title":"Oncogene."},{"issue":"1","key":"2022062015230994400_B51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12974-017-0900-z","article-title":"Identification of the flotillin-1\/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis","volume":"14","author":"Hahn","year":"2017","journal-title":"J Neuroinflammation."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/12\/3611\/1902633\/advancesadv2021005992.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/12\/3611\/1902633\/advancesadv2021005992.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T15:35:40Z","timestamp":1655739340000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/12\/3611\/484426\/The-differential-role-of-the-lipid-raft-associated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,6,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005992","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,20]]}}}